Comparable specimen collection from both ends of at-home mid-turbinate swabs.
Comparable specimen collection from both ends of at-home mid-turbinate swabs.
复制标题
从家用中鼻甲拭子两端采集的可比样本。
DOI:
10.1101/2020.12.05.20244632
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Starita,
中科院分区:
文献类型:
--
作者:
Truong,Melissa;Pfau,Brian;McDermot,Evan;Han,PeterD;Brandstetter,Elisabeth;Richardson,Matthew;Kim,AshleyE;Rieder,MarkJ;Chu,HelenY;Englund,JanetA;Nickerson,DeborahA;Shendure,Jay;Lockwood,ChristinaM;Konnick,EricQ;Starita,
At-home respiratory specimen collection for pathogen testing enables community sampling. Furthermore, it requires neither a health care workerLs time nor personal protective equipment, and symptomatic individuals can continue to self-isolate. However, questions remain as to whether unsupervised upper respiratory specimen collection by individuals in their homes reliably produce specimens that are of high enough quality for pathogen testing. From October 2019 through May 2020, the Seattle Flu Study (1, 2) and the greater Seattle Coronavirus Assessment Network (SCAN; scanpublichealth. org) screened 16,785 midturbinate swabs that were self-collected by participants at home for respiratory pathogens. The at-home kits contained a flocked, midturbinate swab (Copan 56380CS01 or 56750CS01), either adult or pediatric, a tube of universal transport media (UTM), and instructions on how to self-collect a specimen or collect a specimen for a child and return it to the lab (2). Of the kits distributed to individuals in the Seattle metropolitan area, most resulted in swabs returned appropriately according to the instructions in the kit, but 138/16,785 (0.8%) kits were returned to the lab with the swab handle in the UTM tube rather than the swab itself. The swab handle is nontapered, hard plastic with decreased surface area compared with the flocked end of the swab (Fig. 1A). We were puzzled by this phenomenon and sought to evaluate whether handle-collected specimens were comparable to flocked swabs themselves for molecular pathogen detection. We also assessed demographic covariates associated with errors in swab collection. Of the 16,782 specimens, 12,006 were analyzed for the presence of 24 respiratory pathogens using our TaqMan-based detection panel, including 99 of the 138 specimens collected with the handle (Table 1). Samples collected after 1 January 2020 were additionally tested for the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using a separate reverse transcriptase PCR (RT-PCR) assay. As a qualitycontrol metric to determine if a sufficient nasal specimen was collected for each sample, both assay platforms measured the amount of human RNase P. Specimens with RNase P relative cycle threshold (Crt) of. 28 were considered to be a failed collection. The failure rate for all properly collected specimens was 2.0%(238/12,142). We expected a high failure rate for the handle-collected specimens, but only 2.9%(3/102) failed this quality-control metric, a nonsignificant difference (P= 0.46, FisherLs exact test). The Crt values for human marker RNase P for handle-collected specimens were higher than those for properly collected specimens (Fig. 1B), with a mean Crt value of